Physician profile
Michael Devon Bates
NPI 1366676454
$2,023.10
in general payments reported to CMS, 2019-2025
12 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $186 · 2021: $292 · 2022: $124 · 2023: $113 · 2024: $748 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $831.63 | 2019-2025 | Rosa, Mymobility Platform, Persona |
| Atricure, INC. | $335.77 | 2024 | |
| Bone Support INC. | $162.41 | 2019 | |
| Medtronic, INC. | $145.66 | 2024 | Plasmablade(Tm) |
| Peerless Surgical INC. | $124.70 | 2020 | |
| Heraeus Medical, LLC. | $115.95 | 2019 | |
| Osteoremedies, LLC | $100.69 | 2024 | Osteoboost Select 10cc, Biobrush, Biowash Surgical Irrigation |
| Abbott Laboratories | $96.32 | 2022 | |
| Avanos Medical | $43.58 | 2020-2021 | |
| Medacta USA, INC. | $27.19 | 2022 | |
| Medical Device Business Services, INC. | $23.46 | 2021 | |
| Bioventus LLC | $15.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.